According to filings with the U.S. Securities and Exchange Commission, Cagent Vascular has raised $41 Million in new Series D funding. The federal securities law requires the notice to be filed by companies that have…
PHOENIX, Feb. 20, 2025 /PRNewswire/ — Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity Capital”), a leading alternative asset manager, today announced the commitment of $15 million in growth capital to Cagent Vascular Inc., a leading developer of serration technology for vessel dilation in endovascular interventions. This…
Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only Serration Angioplasty Technology February 20, 2024 09:11 AM Eastern Standard Time WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular,…
Wayne, PA – According to filings with the U.S. Securities and Exchange Commission, Cagent Vascular is raising $9,500,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Carol Burns…